![Andrew Kucharchuk](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andrew Kucharchuk
Director of Finance/CFO at
CHAIN BRIDGE I
Net worth: 510 000 $ as of 2026-09-29
Profile
Andrew Albert Kucharchuk occupies the position of Chairman & Chief Executive Officer at Adhera Therapeutics, Inc. He is also on the board of Theralink Technologies, Inc. (Colorado), OncBioMune, Inc. and Theralink Technologies, Inc. (former Chief Financial Officer & Director) and Member of Kappa Alpha Order. Mr. Kucharchuk received an undergraduate degree from Louisiana State University and an MBA from A.B. Freeman School of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
0.33% | 2025-10-02 | 25,000 ( 0.33% ) | 261 875 $ | 2026-09-29 |
0.3% | 2026-04-28 | 25,000 ( 0.3% ) | 248 125 $ | 2026-09-29 |
-.--% | 2026-04-27 | 0 ( -.--% ) | - $ | 2026-09-29 |
Andrew Kucharchuk active positions
| Companies | Position | Start |
|---|---|---|
| CHAIN BRIDGE I | Director of Finance/CFO | 2024-03-31 |
| WINDTREE THERAPEUTICS, INC. | Director/Board Member | 2025-08-02 |
CERo Therapeutics, Inc.
 CERo Therapeutics, Inc. BiotechnologyHealth Technology Engages in development of engineered T-cell therapeutics for the treatment of cancer | Director of Finance/CFO | - |
Kappa Alpha Order | Corporate Officer/Principal | - |
Former positions of Andrew Kucharchuk
| Companies | Position | End |
|---|---|---|
Two Hands Corp.
 Two Hands Corp. Internet RetailRetail Trade Operates online delivery marketplace and operates grocery stores and provides food distribution services | Director of Finance/CFO | 2025-02-19 |
| ADHERA THERAPEUTICS, INC. | Chief Executive Officer | 2022-09-29 |
| THERALINK TECHNOLOGIES, INC. | Chief Executive Officer | 2020-06-04 |
OncBioMune, Inc.
 OncBioMune, Inc. BiotechnologyHealth Technology Develops biotechnologies for cancer treatment | Chief Executive Officer | 2023-08-31 |
Education of Andrew Kucharchuk
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
58
1st degree connections
12
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 12 |
|---|---|
Windtree Therapeutics, Inc.
 Windtree Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel therapeutics to address significant unmet medical needs in acute care markets | Health Technology |
Two Hands Corp.
Two Hands Corp. Internet RetailRetail Trade Operates online delivery marketplace and operates grocery stores and provides food distribution services | Retail Trade |
Louisiana State University
 Louisiana State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tulane University (Louisiana)
 Tulane University (Louisiana) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kappa Alpha Order | |
Adhera Therapeutics, Inc.
 Adhera Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes hypertensive drugs | Health Technology |
A.B. Freeman School of Business
 A.B. Freeman School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Theralink Technologies, Inc. (Colorado)
 Theralink Technologies, Inc. (Colorado) Medical SpecialtiesHealth Technology Engages in the research of human genome sequencing and provides screening test for detection of cancer | Health Technology |
OncBioMune, Inc.
OncBioMune, Inc. BiotechnologyHealth Technology Develops biotechnologies for cancer treatment | Health Technology |
Theralink Technologies, Inc.
 Theralink Technologies, Inc. BiotechnologyHealth Technology Operates as a precision medicine company | Health Technology |
CERo Therapeutics, Inc.
CERo Therapeutics, Inc. BiotechnologyHealth Technology Engages in development of engineered T-cell therapeutics for the treatment of cancer | Health Technology |
Chain Bridge I
 Chain Bridge I Financial ConglomeratesFinance Operates as a blank check company | Finance |
- Stock Market
- Insiders
- Andrew Kucharchuk
